Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

DBV Technologies S.A. DBVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$46.33
+118%

Il y a eu 50 transactions d'initiés récentes enregistrées pour DBV Technologies S.A. (DBVT), dont 24 achats et 18 ventes. Le total des achats d'initiés s'élève à $9.68M et le total des ventes d'initiés à $5.67M.

Les initiés notables ayant une activité récente comprennent Mohideen Pharis, Baker Bros. Advisors Lp, Epic Bpifrance. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — DBVT

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2026-01-29 Mohideen Pharis Chief Medical Officer Vente Informative 534 $4.86 $2.6K 144,995
2026-01-12 Baker Bros. Advisors Lp Director Exercice d'Options (Vente) 25,005,240 - - -
2025-12-18 Epic Bpifrance Other: Member of 10% Owner Group Vente Informative 1,292,103 $4.19 $5.41M 7,303,369
2025-12-17 Epic Bpifrance Other: Member of 10% Owner Group Vente Informative 40,000 $5.28 $211.2K 8,595,472
2025-11-21 Tasse Daniel Chief Executive Officer Attribution de RSU 964,000 $2.90 $2.8M 964,000
2025-11-21 Boucinha Virginie Chief Financial Officer Attribution de RSU 32,000 - - 70,000
2025-11-21 Trapp Kevin Michael Chief Commercial Officer Attribution de RSU 55,000 - - 55,000
2025-11-21 Mohideen Pharis Chief Medical Officer Vente Informative 1,624 $2.77 $4.5K 101,529
2025-11-20 Mohideen Pharis Chief Medical Officer Vente Informative 6,496 $2.88 $18.71K 103,153
2025-11-03 Trapp Kevin Michael Officer Inconnu - - - -
2025-07-29 Mohideen Pharis Chief Medical Officer Vente Informative 464 $2.22 $1.03K 109,649
2025-05-22 Mohideen Pharis Chief Medical Officer Vente Informative 397 $1.84 $730.48 110,113
2025-04-07 Bpifrance Sa 10 Percent Owner Inconnu 6,556,781 - - -
2025-04-07 Epic Bpifrance Other: Member of 10% Owner Group Inconnu 6,556,781 - - -
2025-03-27 Baker Bros. Advisors Lp 10 Percent Owner Attribution de RSU 2,299,656 - - 2,299,656
2025-03-27 Bpifrance Sa 10 Percent Owner Inconnu - - - 226,133
2025-03-27 Bpifrance Investissement S.a.s. Other: Member of 10% Owner Group Inconnu - - - 226,133
2025-03-27 Epic Bpifrance Other: Member of 10% Owner Group Inconnu - - - 226,133
2025-01-30 Mohideen Pharis Chief Medical Officer Vente Informative 600 $0.85 $510.00 110,510
2024-12-04 Tasse Daniel Chief Executive Officer Attribution de RSU 813,200 $0.89 $723.75K 813,200
2024-11-25 Mohideen Pharis Chief Medical Officer Vente Informative 565 $0.57 $322.05 111,110
2024-11-22 Mohideen Pharis Chief Medical Officer Vente Informative 342 $0.53 $181.26 111,675
2024-11-21 Mohideen Pharis Chief Medical Officer Vente Informative 2,350 $0.54 $1.27K 112,017
2024-11-21 Boucinha Virginie Chief Financial Officer Attribution de RSU 19,000 - - 38,000
2024-07-29 Mohideen Pharis Chief Medical Officer Vente Informative 1,785 $0.98 $1.75K 79,367
2024-05-24 Mohideen Pharis Chief Medical Officer Vente Informative 660 $1.36 $897.60 81,152
2024-05-22 Mohideen Pharis Chief Medical Officer Vente Informative 382 $1.38 $527.16 81,812
2024-03-08 Tasse Daniel Chief Executive Officer Achat Informatif 17,094 $0.83 $14.19K 17,094
2024-02-06 Ndu Adora Director Achat Informatif 1,825 $0.89 $1.62K 1,825
2023-11-22 Mohideen Pharis Chief Medical Officer Vente Informative 2,245 $1.74 $3.91K 82,194
2023-11-20 Tasse Daniel Chief Executive Officer Attribution de RSU 806,672 $2.19 $1.77M 806,672
2023-11-20 Mohideen Pharis Chief Medical Officer Attribution de RSU 35,000 - - 84,439
2023-11-20 Boucinha Virginie Chief Financial Officer Attribution de RSU 19,000 - - 19,000
2023-11-06 Boucinha Virginie Officer Inconnu - - - -
2023-08-25 Morris Timothy E Director Achat Informatif 12,000 $1.52 $18.24K 12,000
2023-08-01 Soland Daniel B Director Achat Informatif 15,000 $1.62 $24.3K 20,000
2023-05-24 Mohideen Pharis Chief Medical Officer Vente Informative 469 $3.54 $1.66K 49,439
2022-11-24 Mohideen Pharis Chief Medical Officer Vente Informative 1,792 $2.88 $5.16K 49,908
2022-11-21 Tasse Daniel Chief Executive Officer Attribution de RSU 764,386 $3.07 $2.35M 764,386
2022-11-21 Mohideen Pharis Chief Medical Officer Attribution de RSU 17,500 - - 51,700
2022-11-21 Robitaille Sebastien Chief Financial Officer Attribution de RSU 8,000 - - 36,500
2022-10-03 Guyot-caparros Daniele Director Inconnu - - - -
2022-07-29 Mohideen Pharis Chief Medical Officer Attribution de RSU 10,000 - - 34,200
2022-06-13 Baker Bros. Advisors Lp 10 Percent Owner Attribution de RSU 1,383,352 - - 1,383,352
2022-06-13 Baker Brothers Life Sciences Lp Director Attribution de RSU 1,383,352 - - 1,383,352
2021-11-22 Tasse Daniel Chief Executive Officer Attribution de RSU 274,000 $6.62 $1.81M 274,000
2021-11-22 Mohideen Pharis Chief Medical Officer Attribution de RSU 8,700 - - 24,200
2021-11-22 Robitaille Sebastien Chief Financial Officer Attribution de RSU 5,000 - - 28,500
2021-06-10 De Rosen Michel Director Achat Informatif 6,837 $13.09 $89.5K 6,837
2021-06-10 Morris Timothy E Director Achat Informatif 6,837 $13.09 $89.5K 6,837
Informatif — transaction sur marché ouvert (la plus significative) Non informatif (achat) — récompense, exercice d'option, conversion Non informatif (vente) — retenue fiscale, vente à l'acquisition Neutre — don, fiducie, expiration
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message